MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Clinical trial NCT03291067 · COMPLETED
Trial details
- NCT number
- NCT03291067
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2018-10-19
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.